Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 4Phase 1 4Phase 3 2

Status

Completed 3Terminated 1

Sponsor Class

OTHER 12NETWORK 4NIH 2INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Head & Neck 1

Conditions

Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Inflammatory Breast Neoplasms 1Her2 Positive Metastatic Breast Cancer 1Head and Neck Neoplasms 1

Interventions

Radiotherapy 13Cisplatin 8Cytarabine 7carfilzomib 5Specimen Handling 5Paclitaxel 5Dexamethasone 5Methotrexate 4Lapatinib 4Gemcitabine 4Fluorouracil 4Docetaxel 4Brachytherapy 4Biopsy 4venetoclax 3pomalidomide 3Temozolomide 3Radiotherapy, Conformal 3Leucovorin 3Irinotecan 3Etoposide 3Cyclophosphamide 3Carboplatin 3neratinib 2merphos 2Vincristine 2Radiation 2Polymerase Chain Reaction 2Oxaliplatin 2Immunohistochemistry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × NETWORK × Lapatinib × Clear all
NCT01138384 2023-08-04

Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer

Canadian Cancer Trials Group

Phase 1/2 Completed
19 enrolled
Breast

Breast Neoplasms

NCT00498953 2018-07-09

Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1/2 Completed
7 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00450892 2016-07-07

Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1/2 Completed
129 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01495884 2015-10-26

The Myocet/Lapatinib Study. ICORG 10-03, V5

Cancer Trials Ireland

Phase 1/2 Terminated
11 enrolled
Breast

Her2 Positive Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡